ANEB · Forms 3, 4, 5
Insider trades at Anebulo Pharmaceuticals, Inc.
No open-market insider buys or sells at Anebulo Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Anebulo Pharmaceuticals, Inc. (ANEB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Anebulo Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joseph F. Lawler | Director | Options or other derivatives | Form 4 | ||||
| Bimal R. Shah | Director | Options or other derivatives | Form 4 | ||||
| Kenneth C Cundy | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Jason Aryeh | Director | Options or other derivatives | Form 4 | ||||
| Cunningham, Richard Anthony | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Kenneth Lin | Director | Options or other derivatives | Form 4 | ||||
| Aron R. English | Director | Options or other derivatives | Form 4 | ||||
| Nathaniel Calloway | Director | Options or other derivatives | Form 4 | ||||
| Areta Kupchyk | Director | Options or other derivatives | Form 4 | ||||
| Aron R. English | Director | Buy | 10,101,010 | $0.99 | $10M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.